|
Volumn 10, Issue 3, 2004, Pages
|
Alternate managed care approaches to disease management of allergic rhinitis.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HISTAMINE H1 RECEPTOR ANTAGONIST;
NON PRESCRIPTION DRUG;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
DISEASE MANAGEMENT;
DRUG COST;
ECONOMICS;
HAY FEVER;
HEALTH INSURANCE;
HUMAN;
NOTE;
ORGANIZATION AND MANAGEMENT;
UNITED STATES;
COST BENEFIT ANALYSIS;
HYPERCHOLESTEROLEMIA;
TREATMENT OUTCOME;
DISEASE MANAGEMENT;
DRUG COSTS;
DRUGS, NON-PRESCRIPTION;
HISTAMINE H1 ANTAGONISTS;
HUMANS;
MANAGED CARE PROGRAMS;
RHINITIS, ALLERGIC, SEASONAL;
UNITED STATES;
COST-BENEFIT ANALYSIS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
TREATMENT OUTCOME;
|
EID: 4043113633
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|